BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed BBIO catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:c964f0c4758fe068992b@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261127
DTEND;VALUE=DATE:20261128
SUMMARY:BBIO PDUFA (company-disclosed): PDUFA November 27\, 2026 - BridgeBi
 o Pharma\, Inc.
DESCRIPTION:PDUFA November 27\, 2026 - BridgeBio Pharma\, Inc.\nConfidence:
  company-disclosed\nTicker BBIO (confidence 1.0)\nSource: https://www.sec.
 gov/Archives/edgar/data/1743881/000174388126000033/bbio-20260930xex991.htm
 \nScheduling/reference data from public records\; dates can move. Not inve
 stment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.sec.gov/Archives/edgar/data/1743881/000174388126000033/bbio
 -20260930xex991.htm
CATEGORIES:pdufa,company-disclosed
END:VEVENT
BEGIN:VEVENT
UID:afee2ac9507c5b661bf9@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20280101
DTEND;VALUE=DATE:20280102
SUMMARY:BBIO PDUFA (company-disclosed): infigratinib
DESCRIPTION:PDUFA first half of 2028 - BridgeBio Pharma\, Inc. (infigratini
 b)\nConfidence: company-disclosed\nDate precision: half (shown on the firs
 t day)\nTicker BBIO (confidence 1.0)\nSource: https://www.sec.gov/Archives
 /edgar/data/1743881/000174388126000033/bbio-20260930xex991.htm\nScheduling
 /reference data from public records\; dates can move. Not investment\, leg
 al or medical advice.
TRANSP:TRANSPARENT
URL:https://www.sec.gov/Archives/edgar/data/1743881/000174388126000033/bbio
 -20260930xex991.htm
CATEGORIES:pdufa,company-disclosed
END:VEVENT
END:VCALENDAR
